Search research articles
Contact Us
Filters
Showing results (51-60 of 112) with videos related to
Page
of 12
Sort By:
European Neurology
|
January 1, 1996
Inclusion body myositis: atypical clinical presentations
I Schlesinger, D Soffer, A Lossos, et al.
Magnetic Resonance in Medicine
|
October 25, 2001
Modeling in vivo recovery of intracellular pH in muscle to provide a novel index of proton handling: application to the diagnosis of mitochondrial myopathy
J T Chen, T Taivassalo, Z Argov, et al.
Neurology
|
June 1, 1994
Late-onset muscular weakness in phosphofructokinase deficiency due to exon 5/intron 5 junction point mutation: a unique disorder or the natural course of this glycolytic disorder?
Z Argov, V Barash, D Soffer, et al.
Anesthesiology
|
April 1, 1988
Non-invasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy
J Olgin, Z Argov, H Rosenberg, et al.
Magnetic Resonance in Medicine
|
May 20, 1999
Fitting cytosolic ADP recovery after exercise with a step response function
J T Chen, Z Argov, R E Kearney, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 1, 1994
Familial inflammatory demyelinating polyneuropathy: a Guillain-Barré syndrome variant without autoimmune predilection
I Korn-Lubetzki, I Steiner, T Brenner, et al.
Acta Neurologica Scandinavica
|
February 1, 1985
Immediate spasticity with acute hemiplegia is a sign of basal ganglia hemorrhage
I Steiner, Z Argov, J M Gomori, et al.
European Journal of Neurology
|
January 30, 2014
EFNS/ENS Guidelines for the treatment of ocular myasthenia
E Kerty, A Elsais, Z Argov, et al.
Archives of Neurology
|
January 1, 1984
Patterns of muscle fiber-type disproportion in hypotonic infants
Z Argov, D Gardner-Medwin, M A Johnson, et al.
Neurology
|
June 20, 1998
Facial weakness in hereditary inclusion body myopathies
Z Argov, M Sadeh, I Eisenberg, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 112) with videos related to
Sort By:
Page
of 12
European Neurology
|
January 1, 1996
Inclusion body myositis: atypical clinical presentations
I Schlesinger, D Soffer, A Lossos, et al.
Magnetic Resonance in Medicine
|
October 25, 2001
Modeling in vivo recovery of intracellular pH in muscle to provide a novel index of proton handling: application to the diagnosis of mitochondrial myopathy
J T Chen, T Taivassalo, Z Argov, et al.
Neurology
|
June 1, 1994
Late-onset muscular weakness in phosphofructokinase deficiency due to exon 5/intron 5 junction point mutation: a unique disorder or the natural course of this glycolytic disorder?
Z Argov, V Barash, D Soffer, et al.
Anesthesiology
|
April 1, 1988
Non-invasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy
J Olgin, Z Argov, H Rosenberg, et al.
Magnetic Resonance in Medicine
|
May 20, 1999
Fitting cytosolic ADP recovery after exercise with a step response function
J T Chen, Z Argov, R E Kearney, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 1, 1994
Familial inflammatory demyelinating polyneuropathy: a Guillain-Barré syndrome variant without autoimmune predilection
I Korn-Lubetzki, I Steiner, T Brenner, et al.
Acta Neurologica Scandinavica
|
February 1, 1985
Immediate spasticity with acute hemiplegia is a sign of basal ganglia hemorrhage
I Steiner, Z Argov, J M Gomori, et al.
European Journal of Neurology
|
January 30, 2014
EFNS/ENS Guidelines for the treatment of ocular myasthenia
E Kerty, A Elsais, Z Argov, et al.
Archives of Neurology
|
January 1, 1984
Patterns of muscle fiber-type disproportion in hypotonic infants
Z Argov, D Gardner-Medwin, M A Johnson, et al.
Neurology
|
June 20, 1998
Facial weakness in hereditary inclusion body myopathies
Z Argov, M Sadeh, I Eisenberg, et al.
Page
of 12